Research context
Retatrutide, also known by the research code LY3437943, is a peptide triple-receptor agonist. This description does not identify the MT Peptides catalog material as a clinical medicine.
Primary literature provides context for the molecule; clinical trial material and this catalog item are not treated as interchangeable. Catalog amounts are not human doses, frequency or administration guidance.
Batch-specific identity, purity, stability and sterility data for MT Peptides have not yet been provided. General scientific publications are not a certificate of analysis for this product.
